Related Experiment Videos
[Quantitative evaluation of myocardial ischemia using imaging methods]
P Guéret1, T Bontemps, J L Leymarie
1Clinique cardiologique, CHU Dupuytren, Limoges.
Insights
Secondary prevention strategies for myocardial infarction are crucial for reducing patient mortality. The A.P.S.I. study investigates acetolol
Area of Science:
- Cardiology
- Clinical Trials
- Preventive Medicine
Context:
- Secondary prevention of myocardial infarction (MI) aims to reduce post-MI morbidity and mortality.
- The heterogeneity of MI and evolving treatments complicate natural history understanding.
- Identifying effective preventive measures for high-risk post-MI patients is essential.
Purpose:
- To evaluate the efficacy of acetolol in the secondary prevention of myocardial infarction.
- To address critical questions regarding post-MI patient management and risk stratification.
Summary:
- The A.P.S.I. study focuses on identifying beneficial preventive measures for high-risk patients post-myocardial infarction.
- This research contributes to understanding the evolving landscape of secondary MI prevention.
- Investigating specific interventions like acetolol is key to improving patient outcomes.
Impact:
- Provides insights into optimizing secondary myocardial infarction prevention strategies.
- Aims to improve the long-term prognosis for patients who have experienced a myocardial infarction.
- Contributes evidence for the management of high-risk cardiovascular patient populations.
Abstract:
Secondary prevention of myocardial infarction includes all measures likely to reduce morbidity and mortality after the infarction. It is a highly heterogeneous concept applied to a highly heterogeneous disease. The natural history of myocardial infarction, which must be known to determine the frequency of critical events and hence devise a trial, is incomplete particularly since treatment capable of altering this history (aorto-coronary bypass, thrombolysis) have been introduced. Future trials in secondary prevention of myocardial infarction must concentrate on such important questions as: can the possibilities of reperfusion be extended as regards the acute phase, and which preventive measures are useful to patients at high risk post-infarction? The A.P.S.I. study (acetolol in the secondary prevention of myocardial infarction) is an example of study aimed at answering the second question.